» Authors » R B Jarrett

R B Jarrett

Explore the profile of R B Jarrett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 1515
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vittengl J, Clark L, Thase M, Jarrett R
Psychol Med . 2015 Jun; 45(15):3191-204. PMID: 26098793
Background: The cognitive model of depression suggests that cognitive therapy (CT) improves major depressive disorder (MDD) in part by changing depressive cognitive content (e.g. dysfunctional attitudes, hopelessness). The current analyses...
2.
Dunn T, Vittengl J, Clark L, Carmody T, Thase M, Jarrett R
Psychol Med . 2011 Jul; 42(2):317-26. PMID: 21781377
Background: Major depressive disorder (MDD) is highly prevalent, is recurrent, and impairs people's work, relationships and leisure. Acute-phase treatments improve psychosocial impairment associated with MDD, but how these improvements occur...
3.
Vittengl J, Clark L, Jarrett R
Psychol Med . 2004 Apr; 34(4):643-58. PMID: 15099419
Background: Cognitive therapy reduces depressive symptoms of major depressive disorder, but little is known about concomitant reduction in social-interpersonal dysfunction. Method: We evaluated social-interpersonal functioning (self-reported social adjustment, interpersonal problems...
4.
Jarrett R, Kraft D, Doyle J, FOSTER B, Eaves G, Silver P
Arch Gen Psychiatry . 2001 Apr; 58(4):381-8. PMID: 11296099
Background: Cognitive therapy (CT) may reduce depressive relapse and recurrence when patients learn and use the associated skills. Reported relapse and recurrence rates after CT discontinuation vary widely. The factors...
5.
Jarrett R, Kraft D, Schaffer M, Risser R, Atkins D, Doyle J
Psychother Psychosom . 2000 Aug; 69(5):232-9. PMID: 10965287
Background: Patients with major depressive disorder (MDD) and atypical features have reactive mood plus at least two symptoms: hypersomnia, hyperphagia, leaden paralysis or a lifetime sensitivity to rejection. These patients...
6.
Jarrett R, Schaffer M, McIntire D, Kraft D, Risser R
Arch Gen Psychiatry . 1999 May; 56(5):431-7. PMID: 10232298
Background: Patients with atypical depression are more likely to respond to monoamine oxidase inhibitors than to tricyclic antidepressants. They are frequently offered psychotherapy in the absence of controlled tests. There...
7.
Jarrett R, Basco M, Risser R, Ramanan J, Marwill M, Kraft D, et al.
J Consult Clin Psychol . 1999 Jan; 66(6):1036-40. PMID: 9874918
Two pilot studies evaluated the rate of relapse or recurrence (i.e., major depressive disorder) after cognitive therapy (CT). Two sequential cohorts included outpatients who responded to acute phase CT (A-CT)...
8.
Rush A, Gullion C, Basco M, Jarrett R, Trivedi M
Psychol Med . 1996 May; 26(3):477-86. PMID: 8733206
The psychometric properties of the 28- and 30-item versions of the Inventory of Depressive Symptomatology, Clinician-Rated (IDS-C) and Self-Report (IDS-SR) are reported in a total of 434 (28-item) and 337...
9.
Rush A, Laux G, Giles D, Jarrett R, Weissenburger J, Stone L
J Affect Disord . 1995 Apr; 34(1):25-32. PMID: 7622736
A cross-sectional evaluation of 243 unipolar, nonpsychotic outpatients with major depression was conducted. All subjects were diagnosed by RDC with SADS-L structured interviews. Diagnoses included RDC primary/secondary, RDC endogenous/nonendogenous and...
10.
Jarrett R, Rush A
Psychiatry . 1994 May; 57(2):115-32. PMID: 7938331
Depressive disorders can affect all aspects of a person's functioning and are often associated with significant psychosocial impairment. Such psychosocial problems promote studies of the efficacy of short-term psychotherapy for...